Suppr超能文献

胚系性造血淋巴组织肿瘤易感性。

Germline Predisposition to Hematolymphoid Neoplasia.

机构信息

Department of Pathology, Boston Children's Hospital, Boston, MA.

Department of Pathology, Brigham and Women's Hospital, Boston, MA.

出版信息

Am J Clin Pathol. 2019 Aug 1;152(3):258-276. doi: 10.1093/ajcp/aqz067.

Abstract

OBJECTIVES

The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology aimed to review clinical cases with germline predisposition to hematolymphoid neoplasms.

METHODS

The Workshop Panel reviewed 51 cases with germline mutations and rendered consensus diagnoses. Of these, six cases were presented at the meeting by the submitting pathologists.

RESULTS

The cases submitted to the session covering germline predisposition included 16 cases with germline GATA2 mutations, 10 cases with germline RUNX1 mutations, two cases with germline CEBPA mutations, two germline TP53 mutations, and one case of germline DDX41 mutation. The most common diagnoses were acute myeloid leukemia (15 cases) and myelodysplastic syndrome (MDS, 14 cases).

CONCLUSIONS

The majority of the submitted neoplasms occurring in patients with germline predisposition were myeloid neoplasms with germline mutations in GATA2 and RUNX1. The presence of a germline predisposition mutation is not sufficient for a diagnosis of a neoplasm until the appearance of standard diagnostic features of a hematolymphoid malignancy manifest: in general, the diagnostic criteria for neoplasms associated with germline predisposition disorders are the same as those for sporadic cases.

摘要

目的

血液病理学协会/欧洲血液病理学协会 2017 年研讨会旨在回顾具有血液淋巴肿瘤种系易感性的临床病例。

方法

研讨会小组审查了 51 例种系突变病例,并达成了共识诊断。其中,有 6 例由提交病理学家在会议上展示。

结果

提交给涵盖种系易感性的会议的病例包括 16 例种系 GATA2 突变、10 例种系 RUNX1 突变、2 例种系 CEBPA 突变、2 例种系 TP53 突变和 1 例种系 DDX41 突变。最常见的诊断是急性髓系白血病(15 例)和骨髓增生异常综合征(MDS,14 例)。

结论

发生在具有种系易感性的患者中的大多数新生物是具有 GATA2 和 RUNX1 种系突变的髓系肿瘤。种系易感性突变的存在不足以诊断新生物,除非出现血液淋巴恶性肿瘤的标准诊断特征:一般来说,与种系易感性疾病相关的新生物的诊断标准与散发性病例相同。

相似文献

1
Germline Predisposition to Hematolymphoid Neoplasia.
Am J Clin Pathol. 2019 Aug 1;152(3):258-276. doi: 10.1093/ajcp/aqz067.
2
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Leuk Lymphoma. 2016;57(3):520-36. doi: 10.3109/10428194.2015.1115041. Epub 2015 Dec 23.
5
[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Orv Hetil. 2016 Feb 21;157(8):283-9. doi: 10.1556/650.2016.30375.
6
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
Blood. 2020 May 21;135(21):1882-1886. doi: 10.1182/blood.2019003357.
7
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Best Pract Res Clin Haematol. 2015 Mar;28(1):55-68. doi: 10.1016/j.beha.2014.11.004. Epub 2014 Nov 12.
8
Familial myelodysplasia and acute myeloid leukaemia--a review.
Br J Haematol. 2008 Jan;140(2):123-32. doi: 10.1111/j.1365-2141.2007.06909.x.
9
Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia.
Br J Haematol. 2014 Jan;164(1):142-5. doi: 10.1111/bjh.12559. Epub 2013 Sep 14.
10
Myeloid neoplasms with germline DDX41 mutation.
Int J Hematol. 2017 Aug;106(2):163-174. doi: 10.1007/s12185-017-2260-y. Epub 2017 May 25.

引用本文的文献

1
Germline and somatic drivers in inherited hematologic malignancies.
Front Oncol. 2023 Oct 13;13:1205855. doi: 10.3389/fonc.2023.1205855. eCollection 2023.
2
How I diagnose myeloid neoplasms with germline predisposition.
Am J Clin Pathol. 2023 Oct 3;160(4):352-364. doi: 10.1093/ajcp/aqad075.
4
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
Curr Hematol Malig Rep. 2023 Oct;18(5):121-129. doi: 10.1007/s11899-023-00699-3. Epub 2023 Jun 1.
5
DDX41-associated susceptibility to myeloid neoplasms.
Blood. 2023 Mar 30;141(13):1544-1552. doi: 10.1182/blood.2022017715.
6
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.
Int J Mol Sci. 2022 Oct 4;23(19):11765. doi: 10.3390/ijms231911765.
7
Next-generation sequencing reveals the presence of mutations in acute lymphoblastic leukemia and aplastic anemia.
EJHaem. 2021 Jun 27;2(3):508-513. doi: 10.1002/jha2.256. eCollection 2021 Aug.
8
GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Br J Haematol. 2022 Nov;199(4):482-495. doi: 10.1111/bjh.18330. Epub 2022 Jun 26.
9
Clinical features of mutation-related diseases: a systematic review with individual patient data.
Ther Adv Hematol. 2021 Jul 16;12:20406207211032433. doi: 10.1177/20406207211032433. eCollection 2021.
10
miR-181c regulates MCL1 and cell survival in GATA2 deficient cells.
J Leukoc Biol. 2022 Apr;111(4):805-816. doi: 10.1002/JLB.2A1220-824R. Epub 2021 Jul 16.

本文引用的文献

1
An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Pathol Res Pract. 2019 Mar;215(3):410-413. doi: 10.1016/j.prp.2018.12.025. Epub 2018 Dec 26.
2
Donor-derived MDS/AML in families with germline mutation.
Blood. 2018 Nov 1;132(18):1994-1998. doi: 10.1182/blood-2018-07-861070. Epub 2018 Sep 19.
3
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
Cancer Cell. 2018 May 14;33(5):937-948.e8. doi: 10.1016/j.ccell.2018.03.021. Epub 2018 Apr 19.
4
HSCT for GATA2 deficiency across the pond.
Blood. 2018 Mar 22;131(12):1272-1274. doi: 10.1182/blood-2018-02-826461.
5
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
Leukemia. 2018 May;32(5):1106-1115. doi: 10.1038/s41375-018-0074-4. Epub 2018 Feb 25.
6
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Blood Cancer J. 2018 Feb 13;8(2):19. doi: 10.1038/s41408-018-0049-8.
7
Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen.
Biol Blood Marrow Transplant. 2018 Jun;24(6):1250-1259. doi: 10.1016/j.bbmt.2018.01.030. Epub 2018 Feb 3.
8
Somatic mutations in children with -associated myelodysplastic syndrome who lack other features of GATA2 deficiency.
Blood Adv. 2017 Feb 27;1(7):443-448. doi: 10.1182/bloodadvances.2016002311. eCollection 2017 Feb 28.
9
In vivo T-depleted reduced-intensity transplantation for -related immune dysfunction.
Blood. 2018 Mar 22;131(12):1383-1387. doi: 10.1182/blood-2017-10-811489. Epub 2018 Jan 2.
10
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
Nat Commun. 2017 Dec 19;8(1):2126. doi: 10.1038/s41467-017-02177-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验